Dublin, Ireland, November 16th, 2011, ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that its resourcing division, DOCS, has expanded in Europe by opening four new offices: in Milan, Italy; Budapest, Hungary; Brussels, Belgium and Berlin, Germany. This latest expansion brings the total number of DOCS offices in Europe to 22.
DOCS has been operational in Europe for over 15 years, growing from a small healthcare staffing business to a global provider of resourcing solutions, including functional service provision (FSP), strategic sourcing and permanent placement. DOCS’ European expansion follows its successful launch in Asia-Pacific in early 2011 and it plans to further expand in other key markets, including Latin America, Eastern Europe, the Middle East and Russia, in 2012.
“DOCS has always been strong in Europe and we have a large client and candidate base in the region,” commented Mr Colin Stanley, President, DOCS. “Investing in local support and infrastructure will ensure that we support the current and future needs of both clients and candidates. We have aggressive growth plans for the future and will continue our market expansion in line with these plans.”
DOCS, a division of ICON plc, is a global provider of resourcing solutions to the pharmaceutical, biotechnology and medical device industries. Services range from permanent recruitment and contingent staffing, to strategic sourcing and large-scale FSP (Functional Service Provision). DOCS offers clients access to an extensive global pool of candidates across 38 countries and is an industry leader in the provision of resourcing solutions within the clinical trials industry.
Further information is available at http://www.docsglobal.com
About ICON plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has around 8,300 employees, operating from 79 locations in 38 countries.
Further information is available at www.iconplc.com
+44 (0)20 7067 0594